Charles River Laboratories International Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.19B | $836.8M | $117.6M |
| FY2017 | $1.09B | $1.05B | $163.8M |
| FY2018 | $1.63B | $1.32B | $195.4M |
| FY2019 | — | $1.63B | $238.0M |
| FY2020 | — | $2.11B | $228.4M |